Clearwater2, you have sounded the alarm about your concerns about a prospective PPHM reverse split for quite a while. Now the NASDAQ has extended the timeline for PPHM through at least October 27 to meet their minimum listing requirement, giving PPHM over six more months before the minimum bid price is at issue for listing. If the economy stays soft, further extensions might be expected.
I spot checked your posts and it looks like you first sounded the alarm back on January 7, 2008, which is about 15 months ago. You have been carrying that reverse split torch consistently since.
Of course it is difficult to figure on when PPHM will deliver on results (longs have been off on guestimating when PPHM will deliver on things like the Duke paper and trial results by many months). However, since the reverse split concern was raised well over a year ago and critical NASDAQ timing is over a half year away and can reasonably be expected to be extended, I don't see the 1 for 10 RS being any more of a threat now than it was when you first raised it.
PPHM does need funding if they intend to do Phase 3 without a partnership but PPHM management has also indicated that they don't plan on going it alone. Perhaps, ASCO timing will finally see the release of PPHM trial news that drums up some excitement for PPHM technology?
I entered excerpts from a few of your posts over the last 15 months that serve as a reminder that your reverse split concerns have been hanging out there for quite a while and will likely linger for quite a while longer. Your January 2008 statement that existing shareholders are history because of an imminent reverse split still has a ways to go to be played out.
Best wishes and IMO.
KT
Post: October 24, 2008 #29930
You guys are tripping! Between the company and it's enemies they will make sure the price does not put PPHM back in compliance. PPHM wants, and badly needs to do the RS.
I bet the company and it's planners are upset by the NASDAQ holiday. They will have to push back the dead-set Reverse Split 3 months or so.
Post: August 20, 2008 #27532
Volgat you ask who owns all the shares...I'll give you a hint: some of the people and groups that are committed to passing the RS.
Stealthy I will give you some good advice instead of fighting the RS sell your shares ASAP...you might take a big loss but if you hold thru the RS your loss will be 75-90% greater than it is now.
This RS with 325 Million shares authorized afterwords is exactly what PPHM Management and BOD wants.
Here is one last gem...the RS ratio will be 1 for 10.”
Post: July 8, 2008 #25712
I have to agree with the bashers on one point.
If PPHM executes a RS long term holders are completely screwed. When I say long term holders I mean the stockholders that are holding prior to the RS. Buyers after the RS may have a fighting chance to make a profit.
Unless the stock price starts skyrocketing immediately after the RS....then the pre RS investors can kiss their asses goodbye finacially speaking.
Just to lay it out a little more clearly...I've seen it and been butcherd this way a number of times:
PPHM does a 10 for 1 reverse split... my cost basis is $1.40 per share, the split is done with the stock at .40
The price the morning after is $4 per share. My 200,000 shares became 20,000
There are say 25-28 million shares outstanding after the RS
(warrants included) the company will provision about 100 million authorized as part of the RS vote.
Are you guys getting the picture? Our percentage of ownership is rapidly swirling down the toliet.
Not only will the parties that have been strangling the stock for years attack the post RS price with gusto and tons of cash....but pretty quickly the company will start useing their new found authorized shares to raise capital.
Going back to my 20,000 shares my cost basis was $1.40 per share now it is $14 per share. I would guess that in less than 6 months after the RS the price will be $2.00 per share.
I need $14 just to break even.
The same big pharmas that are holding PPHM under water keep up their dirty tricks for a year or two...maybe the company gets a buyout at $10 or maybe even trial results get the price up to $10...I need $14 just to break even, remember?
PPHM is in a super weak position...this is what it's enemies want and I sometimes wonder if this entire spectacle is not the doing of PPHM management. We the longs of the last 4-6 years have financed their operations...they executed a RS just before the Harvest...the company is a Superstar...and the shareholders are chumps.
If PPHM executes a RS at this point just before stellar/groundbreaking PH 2 results I would be inclined to believe that management had this planned for the last 2-4 years.
What great guys. But that is the reality of the stock markets.
Post: January 8, 2008 #20330
OK my friend, let me lay it out for you. Contrary to what Moby posted companies do not need shareholder approval for a RS...also the number of share authorized for issue does not change unless specified in the RS,
Am I going too fast? After a 10 to 1 RS PPHM has 23-24 million shares outstanding with a share price of $ 4-5.
What is the current number of shares authorized 250 or 275 million?
PPHM management will probably start releasing good news, then great news , then blockbuster news before the post RS price starts getting shorted by BP...
So terry the price starts at $4-5 per share is run up to double digits ($10 plus) on trial results and additional coverage. PPHM has over 200 million shares to sell if need be.
With the share price over $10 per share capitol can be raised by low share count Private Placement or Direct Equity Investment by interested parties.
Funding for PH 3 is not a problem.
As for your question about BP pressuring PPHM I will have to stop laughing so hard to address that one.
I will give you a hint...over the last couple of years BP is unable to attack PPHM's science so all that was left was the shareprice and PPHM's ability to raise capitol.
But you know that well...huh?
Post January 7, 2008 #20268
How discouraging! I just finished reading the R&R report.
It seems obvious to me that a Reverse Split will happen. R&R stated a least 4 times they expect a RS. I don't think they are pulling it out of their *ss. 238 million shares fully outstanding, not too many for a promising Biotech.
Seeing their wonder drugs make it to market is probably the only thing PPHM management cares about. I guess if I were in their shoes I would screw every existing shareholder too.
Say after a 10 to 1 reverse Split they will have 23.8 million shares fully outstanding with lots of fantastic news comming out. If they can break the backs of the determined shorts that have stifled them for so long, they should be able to dilute/print money till Ph.lll
In hindsight the last pipe at .75 per share told the story; Existing shareholders are history!
It seems to me that PPHM management have directed the entire story to this point to execute a Reverse Split just before the company makes headlines.
Discouraging!
News 
Market Data 
Discover 
AI
